BioPharma Credit (LON:BPCR – Get Free Report) insider Graeme Proudfoot bought 70,000 shares of the stock in a transaction dated Tuesday, September 29th. The stock was bought at an average cost of GBX 99 per share, with a total value of £69,300.
BioPharma Credit Price Performance
Shares of BPCR stock opened at GBX 0.98 on Friday. The stock has a market capitalization of £11.00 million, a PE ratio of 0.09 and a beta of 0.23. BioPharma Credit has a 1-year low of GBX 0.88 and a 1-year high of GBX 1. The business has a 50-day moving average of GBX 0.97 and a 200 day moving average of GBX 0.96.
BioPharma Credit Company Profile
See Also
- Five stocks we like better than BioPharma Credit
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
